EyePoint shares plunge more than 66% after disappointing Phase 3 trial results
AI Summary- KTMC is investigating potential federal securities-law violations by EyePoint.
- EyePoint shares fell more than 66% after the trial disclosure.
- EyePoint said DURAVYU failed LUGANO’s prespecified primary endpoint on August 17, 2026.